MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Tuesday, June 21, 2016

12:30pm-2:00pm
Deletions at 22q11.2 in idiopathic Parkinson’s disease: A combined analysis of GWAS data

K.Y. Mok, U. Sheerin, J. Simón-Sánchez, A. Salaka, L. Chester, V. Escott-Price, K. Mantripragada, K.M. Doherty, A.J. Noyce, N.E. Mencacci, S.J. Lubbe, International Parkinson's Disease Genomics Consortium (IPDGC), C.H. Williams-Gray, R.A. Barker, K.D. van Dijk, H.W. Berendse, P. Heutink, J.C. Corvol, F. Cormier, S. Lesage, A. Brice, K. Brockmann, C. Schulte, T. Gasser, T. Foltynie, P. Limousin, K.E. Morrison, C.E. Clarke, S. Sawcer, T.T. Warner, A.J. Lees, H.R. Morris, M.A. Nalls, A.B. Singleton, J. Hardy, A.Y. Abramov, V. Plagnol, N.M. Williams, N.W. Wood (London, United Kingdom)

Genetics (PD and Non-PD)
12:30pm-2:00pm
Depression and apathy in restless legs syndrome

Y. Kaji, K. Ouchi, K. HIrata (Mibu, Japan)

Restless legs syndrome and other sleep disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Detailed proteomic analysis of early PD brain highlights altered expression of mitochondrial proteins as an important event in sporadic PD

S. Gandhi, C.E. Murray, W.E. Heywood, J.L. Holton, K. Mills, T. Revesz (London, United Kingdom)

Pathophysiology
12:30pm-2:00pm
Detection of leucine-rich repeat kinase 2 in human biofluids

E. Mutez, W. Sibran, T. Comptdaer, P. Semaille, M. Drouyer, S. Bleuse, L. Defebvre, A. Destee, M.C. Chartier-Harlin, J.M. Taymans (Lille, France)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Developing a new home monitoring device for dyskinesia in Parkinson’s disease

J.E. Alty, J. Cosgrove, M.A. Lones, S. Jamieson, P. Duggan-Carter, C. Peacey, C. Wicks, R.F. Naylor, A.J. Turner, S.L. Smith (Leeds, United Kingdom)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Development of the UK hereditary spastic paraplegia registry: Analysis of SPAST patients reveals high rate of psychiatric comorbidities

V. Chelban, A. Tucci, H. Houlden (Chisinau, Republic of Moldova)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Diagnostic sensitivity and remote monitoring of motor and non-motor dysfunction in Parkinson’s disease

K. Muhammed, S. Arora, M. Hu, M. Husain (Oxford, United Kingdom)

Technology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Difference of REM sleep behavior disorder between the onset of before and after Parkinson’s disease

T. Nomura, Y. Inoue, K. Nakashima (Yonago, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Differences between responders and non-responders of Istradefylline for the wearing off in Parkinson’s disease

A. Yoritaka, H. Mori, N. Hattori (Saitoma, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Differences of gut bacterial community relate to pathology progress in Parkinson’s disease

T. Minato, S. Hasegawa, Y. Fujisawa, H. Tsuji, T. Asahara, K. Nomoto, A. Okamoto, T. Maeda, K. Ohno, M. Hirayama (Nagoya, Japan)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 48
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley